H|T: The Healthtech Times – Ozempic maker Novo Nordisk buys Montréal’s Inversago for $1 billion
Plus: US Senator questions ethics of Google's Med-PaLM 2. The Healthtech Times is a weekly newsletter covering healthtech news from ...
© Business News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.